Bestrophin 1 and 2 are components of the Ca(2+) activated Cl(-) conductance in mouse airways

René Barro-Soria1, Rainer Schreiber, Karl Kunzelmann

  • 1Institut für Physiologie, Universität Regensburg, Universitätsstrasse 31, D-93053 Regensburg, Germany.

Insights

Bestrophin 1 and 2 play a role in calcium-activated chloride channel (CaCC) function in mouse airways. These proteins are crucial for proper chloride secretion, which is impaired in diseases like cystic fibrosis.

Area of Science:

  • Physiology
  • Molecular Biology
  • Ion Transport

Background:

  • Calcium-activated chloride channels (CaCC) are vital for airway function but their molecular identity remains unclear.
  • Dysfunctional CaCC is implicated in diseases such as cystic fibrosis and polycystic kidney disease.
  • Bestrophin proteins are known to form CaCC and modulate calcium channels.

Purpose of the Study:

  • To investigate the role of bestrophin 1 and bestrophin 2 in calcium-activated chloride secretion in mouse airways.
  • To elucidate the specific contribution of bestrophin paralogs to CaCC activity in the tracheal epithelium.

Main Methods:

  • Ussing chamber recordings on tracheas from bestrophin 1 knockout mice.
  • Whole-cell patch-clamp measurements on primary airway epithelial cells.
  • Short interfering RNA (siRNA) mediated knockdown of bestrophin 2 in knockout cells.
  • RNA interference (RNAi) to suppress both bestrophin 1 and 2.

Main Results:

  • Bestrophin 1 knockout mice exhibited reduced chloride secretion upon ATP stimulation.
  • Knockdown of bestrophin 2 in bestrophin 1 knockout cells further decreased ATP-induced chloride currents.
  • RNAi suppression of both bestrophins significantly reduced CaCC activity.
  • Direct calcium activation of CaCC was also diminished in bestrophin 1 knockout cells.

Conclusions:

  • Bestrophin 1 and bestrophin 2 are essential for calcium-dependent chloride secretion in mouse airways.
  • These findings identify bestrophins as key players in airway ion transport and potential therapeutic targets.